Neurocrine Biosciences, Inc. (NBIX) has a market capitalization of $13.13B and trades at $130.81. The 52-week range is 84.23-160.18.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 27.2, Earnings Per Share (EPS) of $4.81, annual revenue of $2.86B.
The stock has a beta of 0.35, operates in the Healthcare sector.
